HIV-1 (Human Immunodeficiency Virus Type 1) RNA Quantification (Viral load)

The HIV-1 virus weakens the immune system by attacking CD4 cells (a type of white blood cell that helps fight infections). If left untreated, HIV-1 can progress to AIDS (acquired immunodeficiency syndrome), a serious condition where the immune system is severely damaged.

The HIV-1 (Human Immunodeficiency Virus Type 1) RNA Quantification (Viral load) test measures how much HIV is in the blood (viral load). It helps doctors decide when to start HIV medicines, check if antiretroviral therapy (ART) is working, and identify problems such as drug resistance.

This test is needed at the time of HIV diagnosis, when starting or changing antiretroviral therapy, and every 3-6 months during treatment. It can also detect HIV earlier than standard tests in some cases. This is not intended for initial HIV screening; the individual needs a confirmed diagnosis first.

No special preparation is needed for this test. However, it is important to complete the HIV testing consent form and have pre-test counseling (Annexure - CR/01) before giving the sample.

Lab test results may vary across laboratories. Abnormal test results require an expert interpretation. Therefore, never try to self-medicate at home based solely on these results. Always consult a doctor to understand the test results correctly. Regular viral load monitoring helps optimize HIV treatment, protect the immune system, and prevent transmission.

Please note: This is an outsourced test. The sample for this test is collected by TATA 1MG and processed at a NABL accredited partnered lab.